Protecting Consumer Privacy in DTC Tissue Testing
The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters.
dtc genetics
-
Read more: Protecting Consumer Privacy in DTC Tissue Testing -
Read more: Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
Could a corporate, direct-to-consumer cell-based testing service be the next 23andme? And what would that mean for patients?
-
Read more: State Genetic Privacy Statutes: Good Intentions, Unintended Consequences? State Genetic Privacy Statutes: Good Intentions, Unintended Consequences?
Investigative genetic genealogy is a new and complex law enforcement technique that should not be regulated by accident or as an afterthought.
-
Read more: A Proposal for Localized Review to Safeguard Genetic Database Privacy A Proposal for Localized Review to Safeguard Genetic Database Privacy
We must take action to make genetic data sharing more secure and increase the public’s perception of its importance and safety.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of May 2021.
-
Read more: Research Reveals Potential Concerns About Genetic Testing for Suicide Risk Research Reveals Potential Concerns About Genetic Testing for Suicide Risk
Direct-to-consumer genetic tests will soon be able to provide scores that estimate suicide risk, a prospect that raises ethical questions.
-
Read more: Gamete Donor Anonymity is a Myth: Q&A With Seema Mohapatra Gamete Donor Anonymity is a Myth: Q&A With Seema Mohapatra
Gamete donors argue they have a right to privacy. But Seema Mohapatra says the idea of donor privacy is no longer realistic because of the state of genetic technology.
